Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00118404 · ClinicalTrials.gov registry record · Phase 3
Cognitive Therapy for Recurrent Depression
A Phase 3 study of Depression, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 523
- Enrollment target
- 2
- Study locations
NCT00118404 is a Phase 3 study of Depression that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 523 participants, below the 785-participant average among 679 other Depression trials with a reported enrollment target (33% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT00118404, a Phase 3 study of Depression, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 523 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study determined the effectiveness of continuation phase cognitive therapy versus antidepressant medication in preventing relapse of depression in people with recurrent depression.
Conditions Studied
Interventions
- BEHAVIORAL Continuation phase cognitive therapy
- DRUG Continuation phase fluoxetine
- OTHER Continuation phase pill placebo
- BEHAVIORAL Acute phase cognitive therapy
Study Locations (2)
Pennsylvania
- University of Pittsburgh Medical Center Western Psychiatric Institute and Clinic - Pittsburgh
Texas
- University of Texas Southwestern Medical Center at Dallas - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 523 participants |
| Start Date | 2000-03 |
| Est. Completion | 2008-07 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00118404
The ClinicalTrials.gov registry entry for NCT00118404 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 523 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 785-participant average among 679 other Depression trials with a reported enrollment target (33% lower). The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Depression appearing as the primary indexed condition, and to 4 interventions - of which Continuation phase cognitive therapy is the first listed.
NCT00118404 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Pennsylvania, Texas.
Frequently Asked Questions
What is clinical trial NCT00118404 about?
NCT00118404 is a clinical study titled "Cognitive Therapy for Recurrent Depression". This study determined the effectiveness of continuation phase cognitive therapy versus antidepressant medication in preventing relapse of depression in people with recurrent depression.
What is the current status of trial NCT00118404?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 523 participants. The study started on 2000-03. Estimated completion is 2008-07.
What conditions does trial NCT00118404 study?
This clinical trial studies the following conditions: Depression.
What interventions are being tested in trial NCT00118404?
The interventions under investigation include: Continuation phase cognitive therapy (BEHAVIORAL), Continuation phase fluoxetine (DRUG), Continuation phase pill placebo (OTHER), Acute phase cognitive therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT00118404?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00118404 being conducted?
This trial has 2 study locations across Pennsylvania, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Behavioral Activation Delivered Via Home-based Telehealth to Improve Functioning in Cardiovascular Disease Patients Recently Discharged From Inpatient Care
RECRUITING · Phase 3
-
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
RECRUITING · Phase 3
-
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
RECRUITING · Phase 3
-
PCORI Comparative Effectiveness Study-Esketamine (Spravato) vs. Ketamine-Equivalence Study
RECRUITING · Phase 3
-
Creatine for Depressed Male and Female Methamphetamine Users
RECRUITING · Phase 3
-
E-Mindfulness Approaches for Living After Breast Cancer
RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.